Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-19

Clinical Trial Update: A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial update for DU-176b in preventing venous thromboembolism after total knee arthroplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2015-02-19